TINA.org Supports FTC’s ‘Click to Cancel’ Rule against Industry Challenge
Companies should not be able to trap consumers into subscriptions that they do not want.
Vioxx
In August 2013, a federal judge preliminarily approved a $23 million settlement to a class-action lawsuit filed against Merck Sharp & Dohme Corp. for allegedly falsely advertising that Vioxx had greater benefits than the generic versions when these benefits had not been established. According to the settlement terms, class members may receive a cash award of up to $75 with proof of purchase. (In re: Vioxx Products Liability Litigation, MDL No. 1657, E. D. LA.).
The Latest
Rolling Stone Subscriptions
Getting out may not be as easy as signing up.
Menopause Is the Worst. These Everyday Tools Can Help.
Ellen Lee, The New York Times
Obvi
TINA.org discovers the evidence behind these weight-loss claims is slim.
CATrends: Advertised Apartment Rental Prices
Watch out for hidden fees.